Recent Posts

Lululemon drops most since 2020

  Bloomberg Lululemon Athletica Inc shares fell the most since the start of the pandemic after lower-than-expected profitability raised concerns about a pileup of inventory and the yogawear maker’s full-year sales forecast disappointed Wall Street. Gross margin, a key gauge of profitability, was 55.9% in the third quarter, short of analysts’ average estimate of 56.7%. Inventories surged from a year ...

Read More »

New Year holds promise for China IPOs after 2022 haul

  Bloomberg Chinese companies raised a record amount in initial public offerings (IPOs) at home this year, defying a global slump. And with the end of Covid Zero in sight, 2023 could be set for another strong showing. Listings in Shanghai, Shenzhen and the recently inaugurated Beijing exchange brought in $92 billion this year, according to data compiled by Bloomberg. ...

Read More »

Japan’s Takeda secures EU regulatory approval for its dengue vaccine

Bloomberg Takeda Pharmaceutical Co’s dengue vaccine was given the green light for use in Europe, making it the world’s second ever inoculation to be approved to fight the mosquito-borne disease that affects almost 400 million people a year. The European Commission approved the two-shot regimen, called Qdenga, for individuals four years of age and older, Takeda said. Takeda’s shots can ...

Read More »
Send this to a friend